These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24279920)

  • 41. Adverse events after Fluzone ® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013.
    Moro PL; Harrington T; Shimabukuro T; Cano M; Museru OI; Menschik D; Broder K
    Vaccine; 2013 Oct; 31(43):4984-7. PubMed ID: 23994022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010.
    Mayet A; Haus-Cheymol R; Bouaiti EA; Decam C; Simon F; Mérens A; Spiegel A; Meynard JB; Deparis X; Migliani R
    Euro Surveill; 2012 Jun; 17(24):. PubMed ID: 22720768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Towards precision informatics of pharmacovigilance: OAE-CTCAE mapping and OAE-based representation and analysis of adverse events in patients treated with cancer drugs.
    Wong MU; Racz R; Ong E; He Y
    AMIA Annu Symp Proc; 2017; 2017():1793-1801. PubMed ID: 29854250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Ontology of Biological and Clinical Statistics (OBCS) for standardized and reproducible statistical analysis.
    Zheng J; Harris MR; Masci AM; Lin Y; Hero A; Smith B; He Y
    J Biomed Semantics; 2016 Sep; 7(1):53. PubMed ID: 27627881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Databases and in silico tools for vaccine design.
    He Y; Xiang Z
    Methods Mol Biol; 2013; 993():115-27. PubMed ID: 23568467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimating Baseline Incidence of Conditions Potentially Associated with Vaccine Adverse Events: a Call for Surveillance System Using the Korean National Health Insurance Claims Data.
    Huh K; Kim YE; Radnaabaatar M; Lee DH; Kim DW; Shin SA; Jung J
    J Korean Med Sci; 2021 Mar; 36(9):e67. PubMed ID: 33686812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Perez EE; Bokszczanin A; McDonald-McGinn D; Zackai EH; Sullivan KE
    Pediatrics; 2003 Oct; 112(4):e325. PubMed ID: 14523220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Syndromic surveillance of vaccine-associated adverse events in U.S. emergency departments.
    Radhakrishnan L; Stein Z; DeVies J; Smith A; Sheppard M; Hartnett KP; Kite-Powell A; Adjemian J; Rodgers LE
    Vaccine; 2021 Jul; 39(31):4250-4255. PubMed ID: 34167835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: possible role of stimulated reporting and background cases of influenza-like infection.
    Mayet A; Nivoix P; Haus-Cheymol R; De Laval F; Verret C; Duron S; Faure N; Piarroux M; Decam C; Chaudet H; Meynard JB; Deparis X; Migliani R
    Public Health; 2012 Jan; 126(1):70-6. PubMed ID: 22137096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of adverse events in ferrets vaccinated with distemper or rabies vaccine: 143 cases (1995-2001).
    Greenacre CB
    J Am Vet Med Assoc; 2003 Sep; 223(5):663-5. PubMed ID: 12959385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.
    Wang L; Li M; Xie J; Cao Y; Liu H; He Y
    Sci Rep; 2017 Oct; 7(1):13819. PubMed ID: 29061976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease Specific Ontology of Adverse Events: Ontology extension and adaptation for Chronic Kidney Disease.
    Kang Y; Fink JC; Doerfler R; Zhou L
    Comput Biol Med; 2018 Oct; 101():210-217. PubMed ID: 30195820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).
    Braun MM; Mootrey GT; Salive ME; Chen RT; Ellenberg SS
    Pediatrics; 2000 Oct; 106(4):E51. PubMed ID: 11015546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
    Iqbal S; Shi J; Seib K; Lewis P; Moro PL; Woo EJ; Shimabukuro T; Orenstein WA
    Lancet Infect Dis; 2015 Oct; 15(10):1175-1182. PubMed ID: 26289956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics.
    Pomfret TC; Gagnon JM; Gilchrist AT
    J Clin Pharm Ther; 2011 Feb; 36(1):1-9. PubMed ID: 21198715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.
    Pillsbury AJ; Fathima P; Quinn HE; Cashman P; Blyth CC; Leeb A; Macartney KK
    JAMA Netw Open; 2020 May; 3(5):e204079. PubMed ID: 32369177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.